Insider Selling: Trupanion, Inc. (NASDAQ:TRUP) SVP Sells 3,100 Shares of Stock

Trupanion, Inc. (NASDAQ:TRUP) SVP Emily Dreyer sold 3,100 shares of the stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of $54.85, for a total value of $170,035.00. Following the completion of the sale, the senior vice president now directly owns 24,708 shares of the company’s stock, valued at approximately $1,355,233.80. This trade represents a 11.15 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Emily Dreyer also recently made the following trade(s):

• On Monday, November 25th, Emily Dreyer sold 900 shares of Trupanion stock. The shares were sold at an average price of $54.55, for a total value of $49,095.00.

Trupanion Stock Performance

TRUP traded up $0.89 on Tuesday, reaching $54.35. The stock had a trading volume of 321,583 shares, compared to its average volume of 678,444. The business’s 50-day moving average price is $49.19 and its two-hundred day moving average price is $39.67. Trupanion, Inc. has a 12-month low of $19.69 and a 12-month high of $57.90. The company has a market cap of $2.30 billion, a P/E ratio of -169.34 and a beta of 1.69. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.40.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $0.03 EPS for the quarter, beating the consensus estimate of ($0.06) by $0.09. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The firm had revenue of $327.50 million during the quarter, compared to analysts’ expectations of $321.79 million. During the same quarter last year, the firm earned ($0.10) earnings per share. The business’s revenue for the quarter was up 14.6% on a year-over-year basis. Sell-side analysts forecast that Trupanion, Inc. will post -0.23 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Renaissance Technologies LLC purchased a new stake in Trupanion during the 2nd quarter worth about $4,739,000. Marshall Wace LLP boosted its position in shares of Trupanion by 11.9% in the 2nd quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock valued at $32,181,000 after purchasing an additional 116,496 shares during the period. Connors Investor Services Inc. boosted its stake in Trupanion by 31.3% during the 2nd quarter. Connors Investor Services Inc. now owns 113,567 shares of the financial services provider’s stock worth $3,339,000 after purchasing an additional 27,042 shares during the period. Dalton Investments Inc. acquired a new stake in shares of Trupanion during the second quarter worth about $1,029,000. Finally, OmniStar Financial Group Inc. purchased a new position in shares of Trupanion in the 3rd quarter valued at approximately $535,000.

Analyst Upgrades and Downgrades

TRUP has been the topic of several research analyst reports. Bank of America upped their price target on shares of Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a report on Friday, September 20th. Stifel Nicolaus lifted their target price on shares of Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a research note on Monday, September 23rd. Northland Securities increased their price target on shares of Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a research note on Thursday, October 31st. Piper Sandler boosted their price objective on shares of Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a report on Thursday, October 31st. Finally, Evercore ISI raised Trupanion to a “strong-buy” rating in a report on Friday, August 9th. Three analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $44.67.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.